| Robert Michael Holbrook, MD | |
|
1515 N Porter Ave, Suite 200, Norman, OK 73071-6649 | |
| (405) 366-8619 | |
| (405) 366-1839 |
| Full Name | Robert Michael Holbrook |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 24 Years |
| Location | 1515 N Porter Ave, Norman, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053352054 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 22135 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norman Regional | Norman, OK | Hospital |
| Entity Name | Robert M. Holbrook Md, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801824503 PECOS PAC ID: 1658384433 Enrollment ID: O20060720000371 |
News Archive
Previous studies have suggested that increased intake of flavonoids which are common in fruits and vegetables may be associated with a reduced risk of prostate cancer, according to Sanjay Gupta, Ph.D., an assistant professor in the Case School of Medicine Department of Urology.
Although scientists know progressive degeneration of retinal ganglion cells and their axons is the primary cause of glaucoma, researchers have yet to identify a way to stop or prevent the degeneration.
U.S. Physical Therapy, Inc., a leading national operator of outpatient physical therapy clinics, has acquired a majority interest in a six clinic physical therapy group located in the mid-Atlantic region. The practice presently sees approximately 55,000 patient visits per year and produces approximately $4.8 million in annual revenue.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
Researchers at the Stanford University School of Medicine have taken a small but significant step, in mouse studies, toward the goal of transplanting adult stem cells to create a new immune system for people with autoimmune or genetic blood diseases.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Michael Holbrook, MD 1515 N Porter Ave, Suite 200, Norman, OK 73071-6649 Ph: (405) 366-8619 | Robert Michael Holbrook, MD 1515 N Porter Ave, Suite 200, Norman, OK 73071-6649 Ph: (405) 366-8619 |
News Archive
Previous studies have suggested that increased intake of flavonoids which are common in fruits and vegetables may be associated with a reduced risk of prostate cancer, according to Sanjay Gupta, Ph.D., an assistant professor in the Case School of Medicine Department of Urology.
Although scientists know progressive degeneration of retinal ganglion cells and their axons is the primary cause of glaucoma, researchers have yet to identify a way to stop or prevent the degeneration.
U.S. Physical Therapy, Inc., a leading national operator of outpatient physical therapy clinics, has acquired a majority interest in a six clinic physical therapy group located in the mid-Atlantic region. The practice presently sees approximately 55,000 patient visits per year and produces approximately $4.8 million in annual revenue.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
Researchers at the Stanford University School of Medicine have taken a small but significant step, in mouse studies, toward the goal of transplanting adult stem cells to create a new immune system for people with autoimmune or genetic blood diseases.
› Verified 2 days ago
Justin Elliot Fields, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 950 N Porter, Suite 300, Norman, OK 73071 Phone: 405-329-0121 Fax: 405-292-6099 | |
Sunil Thomas Mathew, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3500 Healthplex Pkwy Ste 200, Norman, OK 73072 Phone: 405-515-2222 Fax: 405-515-2208 | |
Aaron Lee Boyd, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 650 24th Ave Sw, Suite 110, Norman, OK 73069 Phone: 405-307-5337 Fax: 405-253-4148 | |
Archana Gautam, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3500 Healthplex Pkwy, Suite 200, Norman, OK 73072 Phone: 405-515-2222 Fax: 405-307-5617 | |
Philip C Bird, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1125 N Porter Ave, Norman, OK 73071 Phone: 405-360-2777 Fax: 405-360-2780 | |
Katherine Hays, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3500 Healthplex Pkwy Ste 200, Norman, OK 73072 Phone: 405-515-2222 Fax: 405-307-5618 |